Cancer Research Cell Death Mechanisms and Cancer Therapy Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krüger, A.
Right arrow Articles by Schmitt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krüger, A.
Right arrow Articles by Schmitt, M.
[Cancer Research 61, 1272-1275, February 15, 2001]
© 2001 American Association for Cancer Research

Advances in Brief

Hydroxamate-Type Matrix Metalloproteinase Inhibitor Batimastat Promotes Liver Metastasis1

Achim Krüger2, Rita Soeltl, Igor Sopov, Charlotte Kopitz, Matthias Arlt, Viktor Magdolen, Nadia Harbeck, Bernd Gänsbacher and Manfred Schmitt

Klinische Forschergruppe der Frauenklinik [A. K., R. S., I. S., V. M., N. H., M. S.], and Institut für Experimentelle Onkologie und Therapieforschung [A. K., C. K., M. A., B. G.], Technische Universität München, D-81675 Munich, Germany

Overexpression of matrix metalloproteinases (MMPs) facilitates tumor cell invasion. Synthetic MMP inhibitors such as batimastat have been designed to treat cancer. We report that because of batimastat treatment, human breast carcinoma cells metastasized to the liver in nude mice and that an increase of liver metastases of murine T-cell lymphoma cells was observed in syngeneic mice. Batimastat treatment also caused liverspecific overexpression of MMPs-2, -9, and mRNA up-regulation of angiogenesis factors and caspase-1, even in tumor-free animals. Induction of organ-specific side effects need to be taken into account regarding further development and clinical use of synthetic MMP inhibitors.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
L. Devy, L. Huang, L. Naa, N. Yanamandra, H. Pieters, N. Frans, E. Chang, Q. Tao, M. Vanhove, A. Lejeune, et al.
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Cancer Res., February 15, 2009; 69(4): 1517 - 1526.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Kopitz, M. Gerg, O. R. Bandapalli, D. Ister, C. J. Pennington, S. Hauser, C. Flechsig, H.-W. Krell, D. Antolovic, K. Brew, et al.
Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling
Cancer Res., September 15, 2007; 67(18): 8615 - 8623.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. B. Acuff, K. J. Carter, B. Fingleton, D. L. Gorden, and L. M. Matrisian
Matrix Metalloproteinase-9 from Bone Marrow-Derived Cells Contributes to Survival but not Growth of Tumor Cells in the Lung Microenvironment
Cancer Res., January 1, 2006; 66(1): 259 - 266.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Kruger, M. J.E. Arlt, M. Gerg, C. Kopitz, M. M. Bernardo, M. Chang, S. Mobashery, and R. Fridman
Antimetastatic Activity of a Novel Mechanism-Based Gelatinase Inhibitor
Cancer Res., May 1, 2005; 65(9): 3523 - 3526.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Van Themsche, T. Alain, A. E. Kossakowska, S. Urbanski, E. F. Potworowski, and Y. St-Pierre
Stromelysin-2 (Matrix Metalloproteinase 10) Is Inducible in Lymphoma Cells and Accelerates the Growth of Lymphoid Tumors In Vivo
J. Immunol., September 15, 2004; 173(6): 3605 - 3611.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
D. D. Boyd and M. Nakajima
Involvement of Heparanase in Tumor Metastases: A New Target in Cancer Therapy?
J Natl Cancer Inst, August 18, 2004; 96(16): 1194 - 1195.
[Full Text] [PDF]

Home page
 JCOHome page
I. S. Aljada, N. Ramnath, K. Donohue, S. Harvey, J. J. Brooks, S. M. Wiseman, T. Khoury, G. Loewen, H. K. Slocum, T. M. Anderson, et al.
Upregulation of the Tissue Inhibitor of Metalloproteinase-1 Protein Is Associated With Progression of Human Non-Small-Cell Lung Cancer
J. Clin. Oncol., August 15, 2004; 22(16): 3218 - 3229.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. L. Andarawewa, A. Boulay, R. Masson, C. Mathelin, I. Stoll, C. Tomasetto, M.-P. Chenard, M. Gintz, J.-P. Bellocq, and M.-C. Rio
Dual Stromelysin-3 Function during Natural Mouse Mammary Tumor Virus-ras Tumor Progression
Cancer Res., September 15, 2003; 63(18): 5844 - 5849.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
O. R.F. Mook, C. Van Overbeek, E. G. Ackema, F. Van Maldegem, and W. M. Frederiks
In Situ Localization of Gelatinolytic Activity in the Extracellular Matrix of Metastases of Colon Cancer in Rat Liver Using Quenched Fluorogenic DQ-gelatin
J. Histochem. Cytochem., June 1, 2003; 51(6): 821 - 829.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
K. Wolf, I. Mazo, H. Leung, K. Engelke, U. H. von Andrian, E. I. Deryugina, A. Y. Strongin, E.-B. Brocker, and P. Friedl
Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis
J. Cell Biol., January 21, 2003; 160(2): 267 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Shiraga, S. Yano, A. Yamamoto, H. Ogawa, H. Goto, T. Miki, K. Miki, H. Zhang, and S. Sone
Organ Heterogeneity of Host-derived Matrix Metalloproteinase Expression and Its Involvement in Multiple-Organ Metastasis by Lung Cancer Cell Lines
Cancer Res., October 15, 2002; 62(20): 5967 - 5973.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Arlt, C. Kopitz, C. Pennington, K. L. M. Watson, H.-W. Krell, W. Bode, B. Gansbacher, R. Khokha, D. R. Edwards, and A. Kruger
Increase in Gelatinase-specificity of Matrix Metalloproteinase Inhibitors Correlates with Antimetastatic Efficacy in a T-Cell Lymphoma Model
Cancer Res., October 1, 2002; 62(19): 5543 - 5550.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
L. M. Coussens, B. Fingleton, and L. M. Matrisian
Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations
Science, March 29, 2002; 295(5564): 2387 - 2392.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. M. Bernardo, S. Brown, Z.-H. Li, R. Fridman, and S. Mobashery
Design, Synthesis, and Characterization of Potent, Slow-binding Inhibitors That Are Selective for Gelatinases
J. Biol. Chem., March 22, 2002; 277(13): 11201 - 11207.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
S. Mechtersheimer, P. Gutwein, N. Agmon-Levin, A. Stoeck, M. Oleszewski, S. Riedle, R. Postina, F. Fahrenholz, M. Fogel, V. Lemmon, et al.
Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins
J. Cell Biol., November 12, 2001; 155(4): 661 - 674.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. S. Pepper
Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis
Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1104 - 1117.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.